Japan Recommends Donanemab, Sets Raft Of New And Reduced Prices

Dupixent, Tezspire Slashed

Japan announced several decisions including new pricing list for NHI and pricing cuts.
Japan sets prices for multiple new drugs, cuts prices of others • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Japan

More from Asia